COMPASS Pathways Stock (NASDAQ:CMPS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.89

52W Range

$5.01 - $12.75

50D Avg

$7.06

200D Avg

$8.28

Market Cap

$424.69M

Avg Vol (3M)

$498.41K

Beta

2.26

Div Yield

-

CMPS Company Profile


COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

GB

Employees

186

IPO Date

Sep 18, 2020

Website

CMPS Performance


CMPS Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-136.92M$-110.40M$-83.22M
Net Income$-118.46M$-91.50M$-71.74M
EBITDA$-136.92M$-96.80M$-75.56M
Basic EPS-$-2.16$-1.79
Diluted EPS-$-2.16$-1.79

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 04, 24 | 1:22 AM
Q1 24May 08, 24 | 12:00 AM
Q4 23Feb 29, 24 | 11:43 AM

Peer Comparison


TickerCompany
DVADaVita Inc.
AMEDAmedisys, Inc.
CCRNCross Country Healthcare, Inc.
SGRYSurgery Partners, Inc.
USPHU.S. Physical Therapy, Inc.
INNVInnovAge Holding Corp.
PNTGThe Pennant Group, Inc.
EHABEnhabit, Inc.
ACHCAcadia Healthcare Company, Inc.
ADUSAddus HomeCare Corporation
ENSGThe Ensign Group, Inc.
AGLagilon health, inc.